A suplementação de Ômega-3 em pacientes com Transtorno do Déficit de Atenção e Hiperatividade
Autor(a) principal: | |
---|---|
Data de Publicação: | 2024 |
Outros Autores: | , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Brazilian Journal of Implantology and Health Sciences |
Texto Completo: | https://bjihs.emnuvens.com.br/bjihs/article/view/1906 |
Resumo: | Attention Deficit Hyperactivity Disorder (ADHD) is a prevalent neurobehavioral disorder, impacting both children and adults. This integrative review highlights the importance of omega-3 fatty acids, especially EPA and DHA, in brain health and ADHD management. The reviewed literature emphasizes the crucial role of diet in brain development, with adequate omega-3 intake associated with improved cognitive and behavioral function. Clinical studies demonstrate that omega-3 supplementation can reduce ADHD symptoms, especially hyperactivity, impulsivity, and inattention. While omega-3 supplementation offers promising benefits for ADHD management, questions regarding dosage and treatment duration are still debated. While some recommendations suggest specific doses for pregnant and lactating women, there are variations in international guidelines. Additionally, the effectiveness of supplementation appears to depend on the dose and ratio of EPA and DHA administered. Therefore, although the findings presented in this review offer valuable insights for clinical practice, further research is needed to establish clear dosage and treatment duration guidelines. This highlights the importance of an individualized approach in the diagnosis and treatment of ADHD, considering the potential benefits of omega-3 supplementation. |
id |
GOE-1_7bf10bba8889a3dd8b8e53a9cf36c309 |
---|---|
oai_identifier_str |
oai:ojs.bjihs.emnuvens.com.br:article/1906 |
network_acronym_str |
GOE-1 |
network_name_str |
Brazilian Journal of Implantology and Health Sciences |
repository_id_str |
|
spelling |
A suplementação de Ômega-3 em pacientes com Transtorno do Déficit de Atenção e HiperatividadeTranstorno do Déficit de Atenção e HiperatividadeÁcidos Graxos Ômega-3NeurodesenvolvimentoSuplementação DietéticaAttention Deficit Hyperactivity Disorder (ADHD) is a prevalent neurobehavioral disorder, impacting both children and adults. This integrative review highlights the importance of omega-3 fatty acids, especially EPA and DHA, in brain health and ADHD management. The reviewed literature emphasizes the crucial role of diet in brain development, with adequate omega-3 intake associated with improved cognitive and behavioral function. Clinical studies demonstrate that omega-3 supplementation can reduce ADHD symptoms, especially hyperactivity, impulsivity, and inattention. While omega-3 supplementation offers promising benefits for ADHD management, questions regarding dosage and treatment duration are still debated. While some recommendations suggest specific doses for pregnant and lactating women, there are variations in international guidelines. Additionally, the effectiveness of supplementation appears to depend on the dose and ratio of EPA and DHA administered. Therefore, although the findings presented in this review offer valuable insights for clinical practice, further research is needed to establish clear dosage and treatment duration guidelines. This highlights the importance of an individualized approach in the diagnosis and treatment of ADHD, considering the potential benefits of omega-3 supplementation.O Transtorno do Déficit de Atenção e Hiperatividade (TDAH) é um distúrbio neurocomportamental prevalente, impactando tanto crianças quanto adultos. Esta revisão integrativa destaca a importância dos ácidos graxos ômega-3, especialmente o EPA e o DHA, na saúde cerebral e no manejo do TDAH. A literatura revisada enfatiza o papel fundamental da dieta no desenvolvimento cerebral, com a ingestão adequada de ômega-3 associada à melhoria da função cognitiva e comportamental. Estudos clínicos demonstram que a suplementação de ômega-3 pode reduzir os sintomas do TDAH, especialmente hiperatividade, impulsividade e desatenção. Embora a suplementação de ômega-3 ofereça benefícios promissores para o manejo do TDAH, questões sobre dosagem e duração do tratamento ainda estão em debate. Enquanto algumas recomendações sugerem doses específicas para gestantes e lactantes, há variações nas diretrizes internacionais. Além disso, a eficácia da suplementação parece depender da dose e proporção de EPA e DHA administradas. Portanto, embora os resultados apresentados nesta revisão ofereçam insights valiosos para a prática clínica, são necessárias mais pesquisas para estabelecer diretrizes claras de dosagem e duração do tratamento. Isso destaca a importância de uma abordagem individualizada no diagnóstico e tratamento do TDAH, considerando os benefícios potenciais da suplementação de ômega-3.Specialized Dentistry Group2024-04-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://bjihs.emnuvens.com.br/bjihs/article/view/190610.36557/2674-8169.2024v6n4p1200-1216Brazilian Journal of Implantology and Health Sciences ; Vol. 6 No. 4 (2024): BJIHS QUALIS B3 - IMPACT FACTOR SJIF 5.807; 1200-1216Brazilian Journal of Implantology and Health Sciences ; Vol. 6 Núm. 4 (2024): BJIHS QUALIS B3 - FATOR DE IMPACTO SJIF 5.807; 1200-1216Brazilian Journal of Implantology and Health Sciences ; v. 6 n. 4 (2024): BJIHS QUALIS B3 - FATOR DE IMPACTO SJIF 5.807; 1200-12162674-8169reponame:Brazilian Journal of Implantology and Health Sciencesinstname:Grupo de Odontologia Especializada (GOE)instacron:GOEporhttps://bjihs.emnuvens.com.br/bjihs/article/view/1906/2126Copyright (c) 2024 Naysa Gabrielly Alves de Andrade, Ana Carolina Oliveira, Bárbara de Oliveira Baptista Savariego, Bianca Mayara Sampaio de Araújo , Fabrício Augusto Rodrigues de Castro, Guilherme Oliveira de Azevedo , Jessica de Oliveira Coimbra, Manoella Lorena Arruda da Silva Cabral Chaves, Maria Zilda Pereira de Araújo, Orisson de Steffani Basso, Rafael Rocha Gonçalves, Sophia de Souza Alves Maiahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessAlves de Andrade, Naysa GabriellyOliveira, Ana Carolina de Oliveira Baptista Savariego, BárbaraSampaio de Araújo , Bianca Mayara Rodrigues de Castro, Fabrício Augusto Oliveira de Azevedo , Guilherme de Oliveira Coimbra, JessicaArruda da Silva Cabral Chaves, Manoella LorenaPereira de Araújo, Maria Zilda de Steffani Basso, OrissonRocha Gonçalves, Rafaelde Souza Alves Maia, Sophia2024-04-12T20:36:26Zoai:ojs.bjihs.emnuvens.com.br:article/1906Revistahttps://bjihs.emnuvens.com.br/bjihsONGhttps://bjihs.emnuvens.com.br/bjihs/oaijournal.bjihs@periodicosbrasil.com.br2674-81692674-8169opendoar:2024-04-12T20:36:26Brazilian Journal of Implantology and Health Sciences - Grupo de Odontologia Especializada (GOE)false |
dc.title.none.fl_str_mv |
A suplementação de Ômega-3 em pacientes com Transtorno do Déficit de Atenção e Hiperatividade |
title |
A suplementação de Ômega-3 em pacientes com Transtorno do Déficit de Atenção e Hiperatividade |
spellingShingle |
A suplementação de Ômega-3 em pacientes com Transtorno do Déficit de Atenção e Hiperatividade Alves de Andrade, Naysa Gabrielly Transtorno do Déficit de Atenção e Hiperatividade Ácidos Graxos Ômega-3 Neurodesenvolvimento Suplementação Dietética |
title_short |
A suplementação de Ômega-3 em pacientes com Transtorno do Déficit de Atenção e Hiperatividade |
title_full |
A suplementação de Ômega-3 em pacientes com Transtorno do Déficit de Atenção e Hiperatividade |
title_fullStr |
A suplementação de Ômega-3 em pacientes com Transtorno do Déficit de Atenção e Hiperatividade |
title_full_unstemmed |
A suplementação de Ômega-3 em pacientes com Transtorno do Déficit de Atenção e Hiperatividade |
title_sort |
A suplementação de Ômega-3 em pacientes com Transtorno do Déficit de Atenção e Hiperatividade |
author |
Alves de Andrade, Naysa Gabrielly |
author_facet |
Alves de Andrade, Naysa Gabrielly Oliveira, Ana Carolina de Oliveira Baptista Savariego, Bárbara Sampaio de Araújo , Bianca Mayara Rodrigues de Castro, Fabrício Augusto Oliveira de Azevedo , Guilherme de Oliveira Coimbra, Jessica Arruda da Silva Cabral Chaves, Manoella Lorena Pereira de Araújo, Maria Zilda de Steffani Basso, Orisson Rocha Gonçalves, Rafael de Souza Alves Maia, Sophia |
author_role |
author |
author2 |
Oliveira, Ana Carolina de Oliveira Baptista Savariego, Bárbara Sampaio de Araújo , Bianca Mayara Rodrigues de Castro, Fabrício Augusto Oliveira de Azevedo , Guilherme de Oliveira Coimbra, Jessica Arruda da Silva Cabral Chaves, Manoella Lorena Pereira de Araújo, Maria Zilda de Steffani Basso, Orisson Rocha Gonçalves, Rafael de Souza Alves Maia, Sophia |
author2_role |
author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Alves de Andrade, Naysa Gabrielly Oliveira, Ana Carolina de Oliveira Baptista Savariego, Bárbara Sampaio de Araújo , Bianca Mayara Rodrigues de Castro, Fabrício Augusto Oliveira de Azevedo , Guilherme de Oliveira Coimbra, Jessica Arruda da Silva Cabral Chaves, Manoella Lorena Pereira de Araújo, Maria Zilda de Steffani Basso, Orisson Rocha Gonçalves, Rafael de Souza Alves Maia, Sophia |
dc.subject.por.fl_str_mv |
Transtorno do Déficit de Atenção e Hiperatividade Ácidos Graxos Ômega-3 Neurodesenvolvimento Suplementação Dietética |
topic |
Transtorno do Déficit de Atenção e Hiperatividade Ácidos Graxos Ômega-3 Neurodesenvolvimento Suplementação Dietética |
description |
Attention Deficit Hyperactivity Disorder (ADHD) is a prevalent neurobehavioral disorder, impacting both children and adults. This integrative review highlights the importance of omega-3 fatty acids, especially EPA and DHA, in brain health and ADHD management. The reviewed literature emphasizes the crucial role of diet in brain development, with adequate omega-3 intake associated with improved cognitive and behavioral function. Clinical studies demonstrate that omega-3 supplementation can reduce ADHD symptoms, especially hyperactivity, impulsivity, and inattention. While omega-3 supplementation offers promising benefits for ADHD management, questions regarding dosage and treatment duration are still debated. While some recommendations suggest specific doses for pregnant and lactating women, there are variations in international guidelines. Additionally, the effectiveness of supplementation appears to depend on the dose and ratio of EPA and DHA administered. Therefore, although the findings presented in this review offer valuable insights for clinical practice, further research is needed to establish clear dosage and treatment duration guidelines. This highlights the importance of an individualized approach in the diagnosis and treatment of ADHD, considering the potential benefits of omega-3 supplementation. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-04-12 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://bjihs.emnuvens.com.br/bjihs/article/view/1906 10.36557/2674-8169.2024v6n4p1200-1216 |
url |
https://bjihs.emnuvens.com.br/bjihs/article/view/1906 |
identifier_str_mv |
10.36557/2674-8169.2024v6n4p1200-1216 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://bjihs.emnuvens.com.br/bjihs/article/view/1906/2126 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Specialized Dentistry Group |
publisher.none.fl_str_mv |
Specialized Dentistry Group |
dc.source.none.fl_str_mv |
Brazilian Journal of Implantology and Health Sciences ; Vol. 6 No. 4 (2024): BJIHS QUALIS B3 - IMPACT FACTOR SJIF 5.807; 1200-1216 Brazilian Journal of Implantology and Health Sciences ; Vol. 6 Núm. 4 (2024): BJIHS QUALIS B3 - FATOR DE IMPACTO SJIF 5.807; 1200-1216 Brazilian Journal of Implantology and Health Sciences ; v. 6 n. 4 (2024): BJIHS QUALIS B3 - FATOR DE IMPACTO SJIF 5.807; 1200-1216 2674-8169 reponame:Brazilian Journal of Implantology and Health Sciences instname:Grupo de Odontologia Especializada (GOE) instacron:GOE |
instname_str |
Grupo de Odontologia Especializada (GOE) |
instacron_str |
GOE |
institution |
GOE |
reponame_str |
Brazilian Journal of Implantology and Health Sciences |
collection |
Brazilian Journal of Implantology and Health Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Implantology and Health Sciences - Grupo de Odontologia Especializada (GOE) |
repository.mail.fl_str_mv |
journal.bjihs@periodicosbrasil.com.br |
_version_ |
1796798447126315008 |